Viking Therapeutics loses a third of its value after oral weight-loss drug trial – MarketWatchRead More
Viking Therapeutics loses a third of its value after oral weightloss drug trial MarketWatch
Related Posts
Newly issued eToro shares jump in Nasdaq debut Its a bullish sign for IPOs MarketWatch
The mobile trading platform’s shares rise 29% in their first day of trading, elevating hopes for upcoming stock-market debuts
US Steel shares surge after Trump backs partnership with Nippon Steel MarketWatch
President Trump's threat of 50% tariffs on European goods, starting June 1, were in focus ahead of the long U.S. holiday weekend. Trump also warned Apple that it faces a…
Trumps tariffs brought carnage to US stocks What it will take to stop it MarketWatch
It’s unclear how long President Trump can afford to sit on the sidelines while markets convulse